mSphere · 2018 · 133 citations · 31 references
Life SciencesMicrobiologyOncologyCarcinogenesisInflammationInnate ImmunityColorectal CancerGastrointestinal InflammationGut MicrobiomeGut MicrobiotaInflammation-associated CarcinogenesisMucosal InflammationC-c Chemokine Receptor 2 SignalingChemokine Receptor AntagonismColitis-associated Colorectal CancerColon Tumor PromotionColorectal Cancer PreventionHost-microbiome Interactions In CancerImmune Modulation By Gut MicrobesMurine Models
The incidence of colorectal cancer (CRC) is rapidly growing worldwide, and there is therefore a greater emphasis on studies of the treatment or prevention of CRC pathogenesis. Recent studies suggested that consideration of the microbiota is unavoidable to understand inflammation and tumorigenesis in the gastrointestinal tract. We demonstrate, using a mouse model of colitis-associated CRC, that human commensal B. fragilis protects against colon tumorigenesis. The protective role against tumor formation provided by B. fragilis is associated with inhibition of expression of the chemokine receptor CCR5 in the colon. The molecular mechanism for protection against CRC provided by B. fragilis is dependent on polysaccharide A production and is mediated by TLR2 signaling. Our results suggest that the commensal microorganism B. fragilis can be used to prevent inflammation-associated CRC development and may provide an effective therapeutic strategy for CRC.
31
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Sarkis K. Mazmanian, Cui Hua Liu, Arthur O. Tzianabos et al. · Cell · 2005 · 2.9K citations · Full text